Denise P. Milot

770 total citations
13 papers, 436 citations indexed

About

Denise P. Milot is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Denise P. Milot has authored 13 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Surgery and 5 papers in Oncology. Recurrent topics in Denise P. Milot's work include Peroxisome Proliferator-Activated Receptors (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). Denise P. Milot is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), Drug Transport and Resistance Mechanisms (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). Denise P. Milot collaborates with scholars based in United States. Denise P. Milot's co-authors include Qiu Guo, Samuel D. Wright, Marc C. Ippolito, Pei-Ran Wang, Yu‐Sheng Chao, Carl P. Sparrow, Charlotte Burton, Margaret Wu, Matt S. Anderson and Suzanne S. Eveland and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Denise P. Milot

13 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise P. Milot United States 12 204 193 132 92 50 13 436
Evelyne Chaput Switzerland 12 211 1.0× 285 1.5× 124 0.9× 138 1.5× 46 0.9× 15 597
Robin Schnitzer‐Polokoff United States 9 244 1.2× 237 1.2× 108 0.8× 59 0.6× 40 0.8× 16 498
Katherine L. Hamelehle United States 14 240 1.2× 235 1.2× 60 0.5× 85 0.9× 123 2.5× 20 524
Hans-Jörg Burger Germany 10 120 0.6× 218 1.1× 68 0.5× 123 1.3× 47 0.9× 14 622
Minoru Tsuda-Tsukimoto Japan 9 180 0.9× 193 1.0× 284 2.2× 155 1.7× 169 3.4× 12 615
Shi‐You Jiang China 8 115 0.6× 194 1.0× 43 0.3× 39 0.4× 45 0.9× 11 390
Harilal Patel India 13 49 0.2× 202 1.0× 72 0.5× 75 0.8× 67 1.3× 46 512
Simon Wong United States 13 52 0.3× 228 1.2× 77 0.6× 100 1.1× 37 0.7× 24 438
Paul D. Uhlendorf United States 9 341 1.7× 186 1.0× 94 0.7× 30 0.3× 18 0.4× 10 515
Hirotaka Kimata Japan 11 271 1.3× 260 1.3× 411 3.1× 55 0.6× 158 3.2× 12 744

Countries citing papers authored by Denise P. Milot

Since Specialization
Citations

This map shows the geographic impact of Denise P. Milot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise P. Milot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise P. Milot more than expected).

Fields of papers citing papers by Denise P. Milot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise P. Milot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise P. Milot. The network helps show where Denise P. Milot may publish in the future.

Co-authorship network of co-authors of Denise P. Milot

This figure shows the co-authorship network connecting the top 25 collaborators of Denise P. Milot. A scholar is included among the top collaborators of Denise P. Milot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise P. Milot. Denise P. Milot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wang, Sheng-Ping, Ying Chen, Haihong Zhou, et al.. (2017). Enhancing Studies of Pharmacodynamic Mechanisms via Measurements of Metabolic Flux: Fundamental Concepts and Guiding Principles for Using Stable Isotope Tracers. Journal of Pharmacology and Experimental Therapeutics. 363(1). 80–91. 10 indexed citations
2.
Sweis, Ramzi F., Julianne A. Hunt, Peter M. Sinclair, et al.. (2011). 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: Attenuation of hERG binding and improved HDLc-raising efficacy. Bioorganic & Medicinal Chemistry Letters. 21(9). 2597–2600. 11 indexed citations
3.
Thompson, Christopher F., Amjad Ali, Zhijian Lu, et al.. (2011). Discovery of Substituted Biphenyl Oxazolidinone Inhibitors of Cholesteryl Ester Transfer Protein. ACS Medicinal Chemistry Letters. 2(6). 424–427. 11 indexed citations
4.
Lu, Zhijian, Ashleigh B. Theberge, Amjad Ali, et al.. (2010). Design of a novel class of biphenyl CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(24). 7469–7472. 11 indexed citations
5.
Sweis, Ramzi F., Julianne A. Hunt, Milton L. Hammond, et al.. (2010). 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: Scaffold design and advancement in HDLc-raising efficacy. Bioorganic & Medicinal Chemistry Letters. 21(6). 1890–1895. 15 indexed citations
6.
Hunt, Julianne A., Milton L. Hammond, James V. Pivnichny, et al.. (2009). 2-Arylbenzoxazoles as CETP inhibitors: Substitution and modification of the α-alkoxyamide moiety. Bioorganic & Medicinal Chemistry Letters. 20(3). 1019–1022. 19 indexed citations
7.
Smith, Cameron J., Amjad Ali, Liya Chen, et al.. (2009). 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety. Bioorganic & Medicinal Chemistry Letters. 20(1). 346–349. 33 indexed citations
8.
Eveland, Suzanne S., Denise P. Milot, Qiu Guo, et al.. (2007). A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology. Analytical Biochemistry. 368(2). 239–249. 13 indexed citations
9.
Lund, Erik, Laurence B. Peterson, Alan D. Adams, et al.. (2005). Different roles of liver X receptor α and β in lipid metabolism: Effects of an α-selective and a dual agonist in mice deficient in each subtype. Biochemical Pharmacology. 71(4). 453–463. 112 indexed citations
10.
Cai, Tian‐Quan, Qiu Guo, Birming Wong, et al.. (2002). Protein-disulfide isomerase is a component of an NBD-cholesterol monomerizing protein complex from hamster small intestine. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1581(3). 100–108. 12 indexed citations
11.
Guo, Qiu, Pei-Ran Wang, Denise P. Milot, et al.. (2001). Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1533(3). 220–232. 53 indexed citations
12.
Wang, Pei-Ran, Qiu Guo, Marc C. Ippolito, et al.. (2001). High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists. European Journal of Pharmacology. 427(3). 285–293. 51 indexed citations
13.
Hermanowski‐Vosatka, Anne, David Gerhold, Steven S. Mundt, et al.. (2000). PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver. Biochemical and Biophysical Research Communications. 279(2). 330–336. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026